Tuberculosis is still one of the deadliest infectious diseases, causing over one million deaths each year worldwide.
Menu
KarXT is providing a novel approach to treatment by not directly blocking dopamine receptors. Credit: Soloveva Anastasiia via www.shutterstock.com. Karuna Therapeutics has announced the submission
NEW YORK–(BUSINESS WIRE)– Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain